Episode Details

Back to Episodes
JAMA Ophthalmology : Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy

JAMA Ophthalmology : Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy

Published 1 year, 2 months ago
Description

Interview with Ehsan Rahimy, MD, author of Mammalian Target Rapamycin Inhibition as a Therapeutic Target for Prevention of Proliferative Vitreoretinopathy. Hosted by Neil Bressler, MD.

Related Content:

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us